Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸
@FilipaLynce
Breast Oncologist @ Dana-Farber Cancer Institute. Director, Dana Farber IBC Program. DFCI Center for BRCA and related genes. Alliance EO. Tweets are my own.
So grateful for this amazing team of patients, advocates and colleagues who work every day to improve the lives of patients diagnosed with IBC! Team IBC at Jimmy Fund Walk 2023 @IBC_DanaFarber @DFCI_BreastOnc @TalkIBC
Extraordinary talk. One of the highlights of our program!
Dr. Marleen Kok (@lab_kok) delivered an excellent #HarvardBreastCancerCourse Schlager Lecture on #Immunotherapy in Early #BreastCancer. The Schlager lectureship brings in world leading cancer investigators working in women's cancers.
Dr Hal Burstein (@HaroldBurstein) moderated the Early #BreastCancer Tumor Board at the #HarvardBreastCancerCourse, where breast oncology experts, @EMittendorfMD #FainaNakhlis @adawaksmd @DrBBychkovsky, @FilipaLynce and #JuliaWong, discussed early breast cancer management through…
Dr. Filipa Lynce (@FilipaLynce) discussed #InflammatoryBreastCancer on Day 1 of the #HarvardBreastCancerCourse, covering clinical challenges and new #IBC research in this aggressive subtype of #BreastCancer. @IBC_DanaFarber
The #HarvardBreastCancerCourse starts on Thursday! 📅July 17 & 18 📍Westin Copley Place, Boston, MA The @harvardmed #BreastCancer course is well suited for medical, surgical & radiation oncologists; breast & general surgeons; internists; physician assistants; nurse practitioners,…
Check out this recent paper on #InflammatoryBreastCancer, it examines the clinicogenomic characterization of #IBC. 👉pubmed.ncbi.nlm.nih.gov/40378057/ @npriedig @DrBBychkovsky @jenniferbellon2 @TariKingMD @DrEricWiner @lmsholl @stolaney1 @nlinmd @FilipaLynce @DrRBarroso…
We’re proud to be included in @Newsweek’s America’s Greatest Workplaces by State 2025 list. This recognition reflects our ongoing commitment to fostering a supportive, inclusive, and mission-driven workplace – one where every team member has the opportunity to thrive and grow.…
A new study led by Dipanjan Chowdhury, PhD, co-director of our Center for BRCA and Related Genes, uncovers why some cancers resist PARP inhibitors. The findings could help guide more personalized treatment strategies. Learn more about the study: bit.ly/4ko5CAq
We call ourselves the 3 musketeers. Today we scored 4% on an MPI R01 that will investigate targeting macrophages in Brca-associated breast cancer. So proud of this dream team. Team science always wins. @FilipaLynce @GShapiroMDPhD @BrighamSurgery @DFCI_BreastOnc
@SusanGKomen, the world’s leading #BreastCancer organization, is awarding $10.8 million in new research grants. “Komen’s commitment to breast cancer research comes at a pivotal time and will drive meaningful advances in our understanding of the disease and care of patients,” said…
Congratulations to Dr. Filipa Lynce (@FilipaLynce) recipient of the Women’s Health Collaboration Award from the @MALifeSciences! This award supports collaborative projects that aim to improve the discovery, technical innovation, and analysis of datasets to answer pressing life…
Study that went under the radar at ASCO. WBRT with hippocampal sparing and memantine versus SRS for 5-20 brain metastases. Same Overall survival, Lower Symptom Burden and Life Interference with SRS, Better KPS with SRS. New standard of care! Congrats Dr. Aizer on this amazing…
Registration open for virtual or in-person participation. A remarkable, thorough and efficient two days of breast cancer updates from the nation's leading breast oncology program @DFCI_BreastOnc @DanaFarber
We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing. oncodaily.com/blog/breast-ca…
Last week we had the chance to celebrate Dr. Panos Konstantinopoulos on his promotion to Professor of Medicine at @harvardmed! Congrats Dr. K🥳
🚨 If you're as serious about breast cancer care as @DrReshmaMahtani, @baik_alan, @antgiorda, @DrSGraff, @claudine_isaacs, @FilipaLynce, @hmcarthur, @DrKEMcCann, @folopade, @kristinrojasmd, @drsarahsam, @Dr_RShatsky, @BCJoyceO then you won't miss #PBCCLive25 in DC! It's the…
👏Congratulations to @DanaFarber's Filipa Lynce, MD, FASCO (@FilipaLynce), recipient of the Advanced Clinical Research Award in #BreastCancer Research from @ConquerCancerFd. Dr. Lynce's work will focus on deciphering mechanisms of response to novel therapies in HER2 expressing…
Dream team breast cancer researchers @DFCI_BreastOnc @DanaFarber pioneering advancement therapeutics for patients #bcsm @ASCO @stolaney1 @AnnPartridgeMD @DrHBurstein @nlinmd @elmayermd @drsarahsam @FilipaLynce @adawaksmd @hthrparsons @IlanaSchlam @esalehiDNP @PTarantinoMD
Happening Now #ASCO25 Poster Session 👉AXALAP: Phase Ib study of axatilimab in combination with olaparib in BRCA1/2 and PALB2-associated metastatic HER2-negative #BreastCancer. @FilipaLynce @AdelaRodrguezH1 @judygarber5 @JennGuerriero 📍Abs: TPS1143 | Poster Bd 110b | Jun 2 |…
Happening Now! #ASCO25 Poster Session 👉Association between chemotherapy use and clinical outcomes in young BRCA carriers with T1N0 #BreastCancer: Results from an international cohort study. @FilipaLynce @matteolambe @AnnPartridgeMD 📍Abs 541 | Poster Bd134 | Jun 2, 9-12 PM CDT…